[Abstract] Primary mammary tumor organoids grown in 3D are an excellent system to study tumor biology. They resemble the organization and physiology of native epithelia more closely than cancer cell lines grown in 2D, and additionally model interactions with the ECM (Boj et al., 2015; Clevers, 2016; Shamir and Ewald, 2014) . Mammary tumor organoids are therefore a promising model system to identify and characterize novel drivers of breast cancer that would be unlikely to be identified using 2D cell lines.
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Procedure
A. Design of antisense oligonucleotides (ASOs)
1. Choose a target gene for knockdown. The protocol described here is specifically suitable for long non-coding RNAs, but knockdown of protein-coding transcripts is equally possible.
2. Design 20-mers complementary to the RNA sequence. Usually, ASOs are designed complementary to exons, but in some cases ASOs targeting introns can be efficient as well.
Design at least two specific ASOs (100% sequence identity) for the target sequence as well as a negative control (e.g., a scrambled ASO control, see (Diermeier et al., 2016) ). It is recommended to start with up to ten individual ASOs for new targets, as not every ASO will result in an efficient knockdown.
3. Use Nucleotide BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to ensure the ASOs are specific to the intended target only. Stringency is important at this step-even one or two mismatches can result in unwanted off-target effects.
4. ASOs used in knockdown experiments carry modified nucleotides to increase binding affinity.
Of the 20 nucleotides, the first and last 5 nucleotides are modified with 2'-O-methoxy-ethyl (MOE). The 10 nucleotides in the middle remain unmodified. In the US, MOE modifications can be ordered e.g., from Integrated DNA Technologies (IDT).
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T. in a plastic
Cryomold and store at -80 °C.
6. Cut the remaining tumor tissue with a scalpel until the tissue pieces are about 2-3 mm in diameter.
7. Transfer the tumor tissue to a 50 ml tube containing 25 ml of collagenase solution (Recipe 1).
8. Shake the collagenase solution containing tumor tissue in an incubator at 100 rpm at 37 °C for 45 min. The suspension now appears cloudy. Over-digestion leads to a large amount of single cells, which should be avoided.
9. Pre-warm DMEM/F12 medium and organoid medium to RT.
10. Pre-warm a 24-well cell culture plate (see Notes 1 and 2) and a 75 cm 2 cell culture flask filled with sterile water to 37 °C.
11. Thaw Matrigel on ice.
12. Centrifuge tube with collagenase solution at 520 x g for 10 min at 25 °C.
13. Aspirate the supernatant using a Pasteur glass pipette connected to vacuum suction, leaving about 1 ml of medium on top of the pellet.
14. Pre-coat a 10 ml sterile pipette tip by pipetting BSA solution (Recipe 2) up and down once. 15. Resuspend the pellet in 10 ml of pre-warmed DMEM/F12 medium using the pre-coated pipette tip.
16. Transfer the suspension to a 15 ml centrifugation tube that has been pre-coated with BSA solution.
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18. Aspirate the supernatant as described in step B13. Pasteur pipettes need not be pre-coated with BSA before use.
19. Resuspend the pellet in 4 ml of DNase solution (Recipe 3) using a pre-coated 10 ml pipette tip.
20. Gently rock by hand for 2-5 min.
21. Add 6 ml of DMEM/F12 and resuspend thoroughly with a pre-coated 10 ml pipette tip.
22. Filter the suspension through a cell strainer into a fresh, pre-coated 15 ml tube to remove large chunks that remain after collagenase digestion.
23. Centrifuge tube at 520 x g for 10 min at 25 °C.
24. Aspirate the supernatant as described in step B13. Pasteur pipettes need not be pre-coated with BSA before use.
25. Resuspend the pellet in 10 ml of DMEM/F12 medium using a pre-coated pipette tip.
26. Pulse-centrifuge tube to 520 x g at 25 °C. Stop the centrifuge as soon as it reaches 520 x g.
27.
Repeat steps B25-B27 three more times (for a total of four times) or until the medium after pulscentrifugation is clear. At the last aspiration step, carefully remove the entire medium.
28. Resuspend the pellet in 10 ml of DMEM/F12 medium using a pre-coated pipette tip.
29. Make sure the suspension is well mixed. Remove 50 µl using a micropipette and transfer to a sterile 5 cm cell culture dish to determine the density of organoids in solution.
30. Count the number of organoids in the 50 µl drop under a microscope. Organoids are counted in the dish, no cover slips are required. An example of a mammary tumor organoid right after preparation is shown in Figure 1 . Depending on the size of the tumor, the total amount of organoids per preparation can vary from approximately 5,000 to 40,000. Organoids that are not needed for the current experiment can be frozen and stored as described in step B42. 39. Leave at least one well untreated and treat at least one well with a scrambled ASO (scASO) as negative controls.
40. Incubate organoids in a cell culture incubator at 5% CO2 and 37 °C.
41. Change the medium to fresh organoid medium and replenish ASOs three days past organoid generation. Organoids should be harvested no later than 6 days post generation (see Note 4).
An example of a mammary organoid cultured for 6 days in the presence of FGF is shown in 
